[go: up one dir, main page]

ITRM20020370A1 - PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR. - Google Patents

PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.

Info

Publication number
ITRM20020370A1
ITRM20020370A1 IT2002RM000370A ITRM20020370A ITRM20020370A1 IT RM20020370 A1 ITRM20020370 A1 IT RM20020370A1 IT 2002RM000370 A IT2002RM000370 A IT 2002RM000370A IT RM20020370 A ITRM20020370 A IT RM20020370A IT RM20020370 A1 ITRM20020370 A1 IT RM20020370A1
Authority
IT
Italy
Prior art keywords
camoid
integrine
peptid
inhibitor
compound containing
Prior art date
Application number
IT2002RM000370A
Other languages
Italian (it)
Inventor
Mauro Marzi
Giuseppe Giannini
Domenico Alloatti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT2002RM000370A priority Critical patent/ITRM20020370A1/en
Publication of ITRM20020370A0 publication Critical patent/ITRM20020370A0/en
Priority to PCT/IT2003/000422 priority patent/WO2004005328A2/en
Priority to AU2003281226A priority patent/AU2003281226A1/en
Publication of ITRM20020370A1 publication Critical patent/ITRM20020370A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2002RM000370A 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR. ITRM20020370A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2002RM000370A ITRM20020370A1 (en) 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.
PCT/IT2003/000422 WO2004005328A2 (en) 2002-07-09 2003-07-03 Peptidomimetic compound useful as inhibitor of integrins
AU2003281226A AU2003281226A1 (en) 2002-07-09 2003-07-03 Peptidomimetic compound useful as inhibitor of integrins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002RM000370A ITRM20020370A1 (en) 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.

Publications (2)

Publication Number Publication Date
ITRM20020370A0 ITRM20020370A0 (en) 2002-07-09
ITRM20020370A1 true ITRM20020370A1 (en) 2004-01-09

Family

ID=11456401

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002RM000370A ITRM20020370A1 (en) 2002-07-09 2002-07-09 PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.

Country Status (3)

Country Link
AU (1) AU2003281226A1 (en)
IT (1) ITRM20020370A1 (en)
WO (1) WO2004005328A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004030494D1 (en) * 2004-10-30 2011-01-20 Univ Pais Vasco B-LACTAM RGD CYCLOPEPTIDES WITH GAMMA (G) INSERTS
CN103374056B (en) * 2012-04-20 2017-02-08 首都医科大学 1-Acetyl-beta-carboline-3-formyl amino-acid benzyl ester, and synthesis and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770565A (en) * 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
US6482821B2 (en) * 1996-12-20 2002-11-19 Hoechst Aktiengellschaft Vitronectin receptor antagonists, their preparation and their use
US6235877B1 (en) * 1999-08-04 2001-05-22 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors

Also Published As

Publication number Publication date
AU2003281226A8 (en) 2004-01-23
AU2003281226A1 (en) 2004-01-23
WO2004005328A2 (en) 2004-01-15
WO2004005328A3 (en) 2004-02-26
ITRM20020370A0 (en) 2002-07-09

Similar Documents

Publication Publication Date Title
DK1414803T3 (en) PYRAZOLYLCARBOXANILIDES AS FUNGICIDES
DE50308694D1 (en) IRRADIATOR T
CY2015028I1 (en) AN N-ACYLOSPHIGOSINE GLYCOSYLOTRANSFERASE INHIBITOR
ATE368042T1 (en) CEPHEMEM COMPOUNDS
NO20052884D0 (en) Substituted indolpyridine compounds as anti-infective agents.
IS7381A (en) compounds
NO20045659L (en) compounds
IS7793A (en) New compound
IS7794A (en) New compound
DK1556377T3 (en) Cyclopropylthienylcarboxamides as fungicides
ITMI20022022A1 (en) ANALOGUES OF NOCICETTINA.
DE60324703D1 (en) BARBITIC ACID DERIVATIVES.
NO20051500D0 (en) Substituted heterocyclylpyrimidines.
ITMI20030479A1 (en) PROCEDURE FOR THE PREPARATION OF A CYAN-ISOBENZOFURANO.
ITRM20020370A1 (en) PEPTID-CAMOID COMPOUND CONTAINING THE RGD SEQUENCE USEFUL AS AN INTEGRINE INHIBITOR.
FI20021010A7 (en) Steel beam
DE60315020D1 (en) (2S) -2-ETHYLPHENYLPROPIONSÄUREDERIVAT
DE50310603D1 (en) splitter basement
NO20032952L (en) show Packaging
SE0203348D0 (en) Novel compounds
UA7208S (en) BEAM
FI5456U1 (en) wooden beam
FI5810U1 (en) shelf
DK1381609T3 (en) 5-Halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides
ITTO20020322A1 (en) DRAWER STRUCTURE.